コカインの抗体触媒による分解

D W Landry¹, K Zhao, G X Yang

¹Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032.

Science (New York, N.Y.)

|March 26, 1993

まとめ

コカインを分解する人工酵素が作られ,コカインの有益な効果を減少させることで,コカイン依存症の新たな治療法となる可能性がある. この予防接種戦略は,コカインを標的にしています.

科学分野:

バイオケミストリーバイオケミストリー
免疫学免疫学とは
薬理学薬理学とは

背景:

コカイン依存症は,治療の選択肢が限られている重要な公衆衛生問題です.
薬物使用障害の現在の治療法は,しばしば行動介入や薬剤に重点を置くが,有効性は様々である.
コカインの代謝経路を理解することは,標的治療戦略の開発に不可欠です.

研究の目的:

コカインを分解できる新しい触媒抗体を開発する.
コカイン依存症の治療として,これらの抗体による被動免疫の可能性を調査する.
エンジニアリングされた抗体によるコカイン水解の有効性を評価する.

主な方法:

モノクローン抗体を生成するために,コカインのトランジション状態のフォスフォナートモノエステルアナログで動物の免疫.
放射性標識されたコカインを使用して,抗体媒介によるコカインの分解を特定し,定量化するための測定法の開発.
抗体によって触媒化されたコカインの水解産物の特徴.

主要な成果:

コカインのベンゾイルエステル群の水解を触媒にできるモノクローナル抗体が成功裏に生成されました.
測定では,コカインをエクゴニンメチルエステルおよびベンゾ酸に分解する活性酵素を特定した.
これらの水解産物には,コカインに伴う刺激作用が欠けています.

結論:

触媒抗体はコカインを効果的に分解し,無効にします.
これらのコカインを水解する抗体による被動免疫は,コカイン依存症の治療のための有望な治療戦略を示しています.
このアプローチは,コカインの強化効果を軽減し,依存症治療に役立ちます.

さらに関連する動画

08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

関連する概念動画

02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...

01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...

01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...

関連する実験動画